- Home
- MVST vs INFU Comparison
MVST vs INFU Comparison
Compare MVST & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVST
- INFU
- Stock Information
- Founded
- MVST 2006
- INFU 2005
- Country
- MVST United States
- INFU United States
- Employees
- MVST N/A
- INFU N/A
- Industry
- MVST Industrial Machinery/Components
- INFU Medical/Dental Instruments
- Sector
- MVST Miscellaneous
- INFU Health Care
- Exchange
- MVST Nasdaq
- INFU Nasdaq
- Market Cap
- MVST 1.3B
- INFU 104.4M
- IPO Year
- MVST N/A
- INFU N/A
- Fundamental
- Price
- MVST $3.01
- INFU $5.88
- Analyst Decision
- MVST Strong Buy
- INFU
- Analyst Count
- MVST 1
- INFU 0
- Target Price
- MVST $3.00
- INFU N/A
- AVG Volume (30 Days)
- MVST 9.2M
- INFU 278.1K
- Earning Date
- MVST 08-07-2025
- INFU 08-07-2025
- Dividend Yield
- MVST N/A
- INFU N/A
- EPS Growth
- MVST N/A
- INFU 3654.89
- EPS
- MVST N/A
- INFU 0.15
- Revenue
- MVST $414,941,000.00
- INFU $137,582,000.00
- Revenue This Year
- MVST $26.08
- INFU $11.08
- Revenue Next Year
- MVST $29.71
- INFU $8.02
- P/E Ratio
- MVST N/A
- INFU $39.38
- Revenue Growth
- MVST 21.68
- INFU 7.98
- 52 Week Low
- MVST $0.15
- INFU $4.61
- 52 Week High
- MVST $4.72
- INFU $9.97
- Technical
- Relative Strength Index (RSI)
- MVST 35.27
- INFU 56.42
- Support Level
- MVST $3.26
- INFU $6.09
- Resistance Level
- MVST $3.67
- INFU $6.40
- Average True Range (ATR)
- MVST 0.26
- INFU 0.26
- MACD
- MVST -0.13
- INFU -0.02
- Stochastic Oscillator
- MVST 3.45
- INFU 65.71
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.